{"organizations": [], "uuid": "3f8cb07222c093185b433f81a1446a2927352adb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?m=02&d=20180410&t=2&i=1250047594&w=1200&r=LYNXMPEE391JO", "site_section": "http://feeds.reuters.com/reuters/businessNews\r", "section_title": "Reuters: Business News", "url": "https://www.reuters.com/article/us-theranos-layoffs/theranos-lays-off-most-of-its-remaining-workforce-wsj-idUSKBN1HH2Z3", "country": "US", "domain_rank": 408, "title": "Theranos lays off most of its remaining workforce: WSJ", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T21:15:00.000+03:00", "replies_count": 0, "uuid": "3f8cb07222c093185b433f81a1446a2927352adb"}, "author": "", "url": "https://www.reuters.com/article/us-theranos-layoffs/theranos-lays-off-most-of-its-remaining-workforce-wsj-idUSKBN1HH2Z3", "ord_in_thread": 0, "title": "Theranos lays off most of its remaining workforce: WSJ", "locations": [], "entities": {"persons": [{"name": "elizabeth holmes", "sentiment": "none"}, {"name": "clinton", "sentiment": "none"}, {"name": "holmes", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "theranos", "sentiment": "none"}], "organizations": [{"name": "theranos", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "theranos inc", "sentiment": "none"}, {"name": "wsj reuters staff", "sentiment": "none"}, {"name": "wall street journal", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "u.s. securities and exchange commission", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Reuters) - Embattled blood-testing company Theranos Inc laid off most of its remaining workforce to preserve cash and avert or at least delay bankruptcy for a few more months, the Wall Street Journal reported on Tuesday, citing people familiar with the matter. \n\nFILE PHOTO: Elizabeth Holmes, CEO of Theranos, attends a panel discussion during the Clinton Global Initiative's annual meeting in New York, September 29, 2015. REUTERS/Brendan McDermid/File Photo The layoffs take the company’s head count from about 125 employees to two dozen or fewer, the Journal reported. \nTheranos and its chief executive, Elizabeth Holmes, agreed to settle “massive fraud” charges with the U.S. Securities and Exchange Commission last month. \nUnder the SEC settlement, Holmes was forced to relinquish her voting control over the company she founded, return millions of shares to the privately held company and pay a $500,000 penalty. \nHolmes also agreed to be barred from serving as an officer or director of a public company for 10 years. \nThe company did not immediately respond to a request for comment. \nReporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Anil D'Silva\n ", "external_links": [], "published": "2018-04-10T21:15:00.000+03:00", "crawled": "2018-04-10T21:27:43.000+03:00", "highlightTitle": ""}